These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21287339)

  • 1. Assessment of suppressive capacity by human regulatory T cells using a reproducible, bi-directional CFSE-based in vitro assay.
    Schneider A; Buckner JH
    Methods Mol Biol; 2011; 707():233-41. PubMed ID: 21287339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
    Boks MA; Zwaginga JJ; van Ham SM; ten Brinke A
    Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
    Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
    J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized method for the functional analysis of human regulatory T cells.
    Oberg HH; Wesch D; Lenke J; Kabelitz D
    Scand J Immunol; 2006 Sep; 64(3):353-60. PubMed ID: 16918705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
    Hilchey SP; Bernstein SH
    Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression assays with human T regulatory cells: a technical guide.
    McMurchy AN; Levings MK
    Eur J Immunol; 2012 Jan; 42(1):27-34. PubMed ID: 22161814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the in vitro suppressive capacity of regulatory T cells.
    Brusko TM; Hulme MA; Myhr CB; Haller MJ; Atkinson MA
    Immunol Invest; 2007; 36(5-6):607-28. PubMed ID: 18161521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
    Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
    Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
    Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
    J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity.
    Levings MK; Allan S; d'Hennezel E; Piccirillo CA
    Adv Immunol; 2006; 92():119-55. PubMed ID: 17145303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro suppression assay for functional assessment of human regulatory T cells.
    Tran DQ
    Methods Mol Biol; 2013; 979():199-212. PubMed ID: 23397398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and function of naturally occurring CD4+CD25+ regulatory T cells.
    Toda A; Piccirillo CA
    J Leukoc Biol; 2006 Sep; 80(3):458-70. PubMed ID: 16809644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells: history and perspective.
    Sakaguchi S
    Methods Mol Biol; 2011; 707():3-17. PubMed ID: 21287325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion.
    Miyara M; Wing K; Sakaguchi S
    J Allergy Clin Immunol; 2009 Apr; 123(4):749-55; quiz 756-7. PubMed ID: 19348913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
    Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential.
    Masteller EL; Tang Q; Bluestone JA
    Semin Immunol; 2006 Apr; 18(2):103-10. PubMed ID: 16458533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
    Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
    J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.